1. Home
  2. TMDE vs LSTA Comparison

TMDE vs LSTA Comparison

Compare TMDE & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TMDE

TMD Energy Limited Ordinary Shares

HOLD

Current Price

$0.63

Market Cap

18.9M

Sector

Energy

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.04

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDE
LSTA
Founded
2016
1980
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Misc Health and Biotechnology Services
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
20.9M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
TMDE
LSTA
Price
$0.63
$2.04
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
18.3K
23.8K
Earning Date
09-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$607,422,733.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$1.81
52 Week High
$6.27
$4.20

Technical Indicators

Market Signals
Indicator
TMDE
LSTA
Relative Strength Index (RSI) 36.90 46.57
Support Level $0.69 $1.85
Resistance Level $0.78 $2.15
Average True Range (ATR) 0.05 0.14
MACD -0.01 0.02
Stochastic Oscillator 15.44 59.53

Price Performance

Historical Comparison
TMDE
LSTA

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: